We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Intravitreal Injections of Sirolimus in the Treatment of Geographic Atrophy (Sirolimus)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01675947
Recruitment Status : Terminated (On May 30, 2014, study injections were discontinued at the request of the DSMC. No further recruitment will occur.)
First Posted : August 30, 2012
Last Update Posted : December 10, 2015
The EMMES Corporation
Santen Inc.
Information provided by (Responsible Party):
National Eye Institute (NEI)

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : June 2015
  Estimated Study Completion Date : February 2016